Integrated Care for Traumatic Brain Injury and Substance Use Disorder
(ExpandAccess Trial)
Trial Summary
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Integrated Model of Care treatment for Traumatic Brain Injury and Substance Use Disorder?
Is the Integrated Care for Traumatic Brain Injury and Substance Use Disorder generally safe for humans?
The research articles do not provide specific safety data for the Integrated Care model for Traumatic Brain Injury and Substance Use Disorder. However, they highlight the importance of integrating substance use screening and tailored care in treatment protocols to optimize management and resource utilization for TBI patients with substance use issues.36789
What makes the Integrated Model of Care treatment unique for traumatic brain injury and substance use disorder?
The Integrated Model of Care is unique because it combines treatment for traumatic brain injury (TBI) and substance use disorder (SUD) into a single, cohesive approach, addressing both conditions simultaneously rather than separately. This integrated care model aims to overcome the fragmentation in healthcare services by using multidisciplinary teams and cognitive accommodations to provide comprehensive support for individuals with both TBI and SUD.12101112
What is the purpose of this trial?
The purpose of this research is to determine whether military veterans and service members with mild traumatic brain injury with and without co-occurring substance use can complete and benefit from integrated interdisciplinary care individualized to their symptoms, goals, and needs.Participants will complete surveys about substance use and other symptoms at the beginning and end of treatment in an intensive outpatient program and 6 months after discharge.
Eligibility Criteria
This trial is for military veterans and service members who have experienced a mild traumatic brain injury (mTBI), also known as a concussion, with or without substance use issues. Specific eligibility criteria are not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intensive Outpatient Program (IOP) Treatment
Participants engage in interdisciplinary intensive outpatient program treatment for mild traumatic brain injury with individualized support for substance use
Transition Support Program
Participants receive support for substance use in the transition support program following the IOP treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 6 months post-treatment
Treatment Details
Interventions
- Integrated Model of Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shepherd Center, Atlanta GA
Lead Sponsor